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OR I G I N A L R E S E A R C H
Gold nanoparticles affect the antioxidant status in
selected normal human cells
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International Journal of Nanomedicine
Noami Daems1
Sébastien Penninckx2
Inge Nelissen3
Karen Van Hoecke4
Thomas Cardinaels4,5
Sarah Baatout1
Carine Michiels6
Stéphane Lucas2
An Aerts1
1Radiobiology Research Unit,
Interdisciplinary Biosciences, Institute for
Environment, Health and Safety, Belgian
Nuclear Research Centre (SCK.CEN),
Mol, Belgium; 2Research Center for the
Physics of Matter and Radiation-NARILIS,
University of Namur, Namur, Belgium;
3Health Department, Flemish Institute
For Technological Research (VITO), Mol,
Belgium; 4Radiochemistry Expert Group,
Institute for Nuclear Materials Science,
Belgian Nuclear Research Centre (SCK.
CEN), Mol, Belgium; 5Department of
Chemistry, KU Leuven, Heverlee,
Belgium; 6Unité de Recherche en Biologie
Cellulaire-NARILIS, University of Namur,
Namur, Belgium
Purpose: This study evaluates the cytotoxicity of AuNPs coated with polyallylamine
(AuNPs-PAA) and conjugated or not to the epidermal growth factor receptor (EGFR)-
targeting antibody Cetuximab (AuNPs-PAA-Ctxb) in normal human kidney (HK-2), liver
(THLE-2) and microvascular endothelial (TIME) cells, and compares it with two cancer cell
lines that are EGFR-overexpressing (A431) or EGFR-negative (MDA-MB-453).
Results: Conjugation of Cetuximab to AuNPs-PAA increased the AuNPs-PAA-Ctxb inter-
actions with cells, but reduced their cytotoxicity. TIME cells exhibited the strongest reduc-
tion in viability after exposure to AuNPs-PAA(±Ctxb), followed by THLE-2, MDA-MB-453,
HK-2 and A431 cells. This cell type-dependent sensitivity was strongly correlated to the
inhibition of thioredoxin reductase (TrxR) and glutathione reductase (GR), and to the
depolarization of the mitochondrial membrane potential. Both are suggested to initiate
apoptosis, which was indeed detected in a concentration- and time-dependent manner. The
role of oxidative stress in AuNPs-PAA(±Ctxb)-induced cytotoxicity was demonstrated by co-
incubation of the cells with N-acetyl L-cysteine (NAC), which signiﬁcantly decreased
apoptosis and mitochondrial membrane depolarization.
Conclusion: This study helps to identify the cells and tissues that could be sensitive to
AuNPs and deepens the understanding of the risks associated with the use of AuNPs in vivo.
Keywords: cytotoxicity, EGFR, Cetuximab, oxidative stress
Introduction
In order to improve cancer detection and therapy efﬁciency, gold nanoparticles
(AuNPs) are emerging as promising contrast agents, drug delivery vehicles, photo-
thermal agents and radiosensitizers.1–9 Functional surface modiﬁcations are typi-
cally applied to actively target the cancer cells.10–13 In our team, 5 nm AuNPs are
synthesized and coated with organic polyallylamine (AuNPs-PAA) by plasma vapor
deposition. AuNPs-PAA are subsequently conjugated to Cetuximab (AuNPs-PAA-
Ctxb), a commercially available antibody targeting the epidermal growth factor
receptor (EGFR), which is overexpressed in numerous tumor types.14 The resulting
nanoconjugates are able to selectively target EGFR-overexpressing cancer cells in
vitro and in vivo, and exhibit an in vivo pharmacokinetic proﬁle similar to that of
unconjugated Cetuximab. However, the reticuloendothelial system (RES) in the
liver and spleen rapidly sequestrates AuNPs-PAA-Ctxb.15,16 This phenomenon has
been demonstrated by several other in vivo biodistribution studies and is the main
reason why clinical success of AuNPs remains, in general, elusive.15,17–22 In
addition, accumulation of AuNPs-PAA-Ctxb and other AuNPs has been demon-
strated in the kidneys, which are particularly sensitive to xenobiotics due to their
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high degree of vascularization and their ability to concen-
trate toxins.15–17,23–26 In conclusion, since AuNPs accu-
mulate in several non-target organs in vivo, it is essential
to assess the potential toxicity of AuNPs in these healthy
cells and tissues before AuNPs can be used in a clinical
setting.27
Due to their small size, nanoparticles generally exhibit
different characteristics and have a higher reactivity com-
pared to their bulk counterparts. Various studies have
reported that AuNPs are able to induce formation of reactive
oxygen species (ROS) in cells, which would be the major
cause of cellular damage, genotoxicity and cell death.28–30 In
addition, abnormalities in tissue morphology of the kidney,
the liver and the spleen and a minor increase in lung inﬂam-
mation were detected in rodents after exposure to
AuNPs.24,31–34 However, these ﬁndings contradict to those
of other research groups that have demonstrated that AuNPs
exhibit no toxic health effects at all in vitro and in vivo.35–37
These conﬂicting results in the literature indicate that it is
difﬁcult to predict the toxicity of AuNPs in different biolo-
gical systems, and that this depends strongly on their physi-
cochemical properties including particle size, shape, surface
coating, surface charge and adsorbed protein corona.36,38–42
In this study, we characterized our in-house produced
AuNPs-PAA and AuNPs-PAA-Ctxb in terms of their size
and surface charge. Furthermore, we evaluated and com-
pared the cellular uptake and cytotoxic effects of the
AuNPs-PAA and AuNPs-PAA-Ctxb on human microvascu-
lar endothelial (TIME) cells, human proximal tubular kidney
(HK-2) cells and human liver (THLE-2) cells. These three
cell types were chosen because they originate from normal
human primary cells, retaining their phenotypic and func-
tional characteristics. Furthermore, since these cell types are
exposed to a signiﬁcant amount of AuNPs in vivo, they are
suitable in vitro models for the estimation and understanding
of the nanoparticle toxicity on human health, such as vascular
toxicity, nephrotoxicity and hepatotoxicity.15,17–22 Indeed,
microvascular endothelial cells are the ﬁrst cells to encounter
the AuNPs after intravenous injections and are responsible
for the transport and exchange of the AuNPs from the blood-
stream to the tissues. Renal tubular cells are exposed to
AuNPs after their ﬁltration through the glomerular capillary
wall during renal excretion. Finally, although Kupffer cells in
the liver have a high phagocytic capacity to sequestrate
AuNPs, the hepatocytes are part of the hepatobiliary system,
which represents an important pathway for nanoparticle pro-
cessing and thus forms a potential site for toxicity.43 In
addition to these non-cancerous cell types, EGFR-
overexpressing A431 cells and EGFR-negative MDA-MB-
453 cancer cell lines were used as positive and negative
controls, respectively, for antibody targeting. Cytotoxicity
was assessed by following the number of viable cells and
measuring the mitochondrial membrane potential, the thior-
edoxin reductase and glutathione reductase activity, and the
extent of apoptotic cell death. In order to explore the role of
oxidative stress, the possible protective effect of N-acetyl L-
cysteine (NAC) was studied. If a situation applies for both
AuNPs-PAA and AuNPs-PAA-Ctxb, we will refer to them as
AuNPs-PAA(±Ctxb) in the remainder of the manuscript.
This work contributes to a better estimation of the potential
negative effects of therapeutic AuNPs formulations on
human health.
Materials and methods
Chemicals
Polyallylamine, (1-Cyano-2-ethoxy-2-oxoethylidenami-
nooxy) dimethylamino-morpholino-carbenium hexaﬂuoro-
phosphate (COMU), Arabic gum, NAC, CelLytic M, the
bicinchoninic acid (BCA) protein assay kit, the
Thioredoxin reductase assay kit, bovine serum albumin
(BSA), non-fat dry milk, phosphatase inhibitor tablets
(PhosStop) and the Complete Mini EDTA-free Protease
Inhibitor Cocktail were purchased from Sigma-Aldrich
(Diegem, Belgium). Cetuximab (Erbitux® 5 mg/ml) was
kindly provided by the Sint-Dimpna Hospital (Geel,
Belgium). Vivaspin® centrifugal concentrators and caco-
dylate buffer were obtained from Merck (Overijse,
Belgium). All cell lines, the Microvascular Endothelial
Cell Growth Kit-VEGF and EGF were obtained from
ATCC (Molsheim Cedex, France). Fetal bovine serum
(FBS), Dulbecco’s modiﬁed Eagle’s medium (DMEM),
DMEM:F12, phosphate buffered saline (PBS) tablets and
penicillin-streptomycin were purchased from Gibco (Aalst,
Belgium). The BEGM Bullet Kit was received from Lonza
(Verviers, Belgium). The CellTiter 96 Aqueous One
Solution Cell Proliferation Assay was purchased from
Promega (Leiden, The Netherlands). The IncuCyte
Caspase 3/7 Green Reagent and the IncuCyte Annexin V
Red Reagent were obtained from Essen BioScience
(Hertfordshire, UK). TGX Stain-free Precast Protein
Gels, Trans-Blot Turbo Mini Nitrocellulose Transfer
Packs and the Clarity Western ECL substrate kit were
provided by Bio-Rad Laboratories (Temse, Belgium).
The rabbit anti-EGFR antibody was purchased from Cell
Signaling Technology (Leiden, The Netherlands). The
Daems et al Dovepress
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mouse anti-β actin antibody was purchased from Santa
Cruz Biotechnology (Heidelberg, Germany). HRP-labeled
goat anti-rabbit antibody, goat-anti mouse antibody and
tetramethylrhodamine, methyl ester, perchlorate (TMRM)
were obtained from Invitrogen (Merelbeke, Belgium).
Glutaraldehyde and osmic acid were received from Agar
Scientiﬁc (Essex, UK). The Eponate 12 Embedding Kit
with BDMAwas purchased from Ted Pella (Paris, France).
The Glutathione Reductase Assay kit was obtained from
Abcam (Cambridge, UK). Nitric acid (HNO3), hydrochlo-
ric acid (HCl), hydrogen peroxide (H2O2) and hydroﬂuoric
acid (HF) were of trace metal grade and purchased from
Fisher Scientiﬁc (Merelbeke, Belgium). SPEX Certiprep
certiﬁed standard solutions (Boom B.V., Meppel, The
Netherlands) were used to prepare the calibration stan-
dards and internal standards.
Production of AuNPs-PAA and
Cetuximab conjugation
The AuNPs were produced and coated with PAA by physical
plasma vapor deposition as described previously.14 The result-
ing PAA-coated AuNPs (AuNPs-PAA) were dispersed in
acetate buffer (pH 5) under pulsed sonication (50 W,
30 kHz, 20% amplitude, 0.5 sec pulses), and were subse-
quently puriﬁed from excess PAA and NaCl by ﬁltration in a
centrifugal ﬁlter unit with a molecular cut-off of 10 kDa.
Cetuximab was puriﬁed by ﬁltration in a centrifugal ﬁlter
unit with a molecular cut-off of 10 kDa, after which it was
lyophilized (LABCONCO, Osterode, Germany). Lyophilized
Cetuximab and COMU were dissolved in 0.01 M PBS to a
concentration of 1 mg/mL and 1.5 mg/mL, respectively. The
Cetuximab and COMU solutions were mixed and the pH was
adjusted to 7 with 0.1 M HCl. Then, the AuNPs-PAA were
added to the Cetuximab-COMU mixture to achieve a ﬁnal
concentration of 0.24 mg/ml, 0.43 mg/mL and 0.17 mg/mL of
Cetuximab, COMU and gold, respectively. The mixture was
stirred for 4 h at room temperature, after which it was puriﬁed
with a centrifugal ﬁlter unit with a molecular cut-off of
300 kDa. The AuNPs-PAA-Ctxb were lyophilized for long-
term storage after the addition of 3% arabic gum as stabilizer,
which also causes steric repulsion between the nanoparticles
when they are re-suspended after the freeze-drying process.
Nanoparticle characterization (Zeta
potential and size distribution)
Lyophilized AuNPs-PAA(±Ctxb) were dispersed in Class
1 water, DMEM or DMEM with 10% (v/v) FBS to a gold
concentration of 80 µg/ml. The size distribution of the
nanoparticles was characterized by means of CPS Disc
Centrifugation (Benelux Scientiﬁc, Eke, Belgium). A rota-
tional speed of 22,000 r.p.m., a sucrose density gradient of
2–8% with a ﬂuid density of 1.017 g/mL and a refractive
index of 1.341 were employed. The measurement range of
the instrument was set from 3.5 nm to 50 µm. The particle
density was set to 10.05 g/mL and the particle refractive
index to 0.47. Each measurement was calibrated with
certiﬁed PVC microparticles provided by CPS
Instruments, having a peak diameter of 0.263 µm and a
particle density of 1.386 g/ml. The peak particle sizes and
the 5th and 95th percentiles were extracted from relative
number size distributions. The zeta potential was deter-
mined with the Nanosizer Nano ZSP (Malvern P analyti-
cal, Brussels, Belgium) with a temperature equilibration
time of 2 min at 25 °C. A dispersant refractive index of
1.330, a viscosity of 0.8872 cP and a dispersant dielectric
constant of 78.5 were used. UV-Vis spectra were recorded
on the CLARIOstar microplate reader (BMS Labtech, De
Meern, Netherlands). Conjugation of Cetuximab to
AuNPs-PAA was also conﬁrmed by SDS-PAGE. 10 µg
of Cetuximab, Cetuximab + AuNPs-PAA and AuNPs-
PAA-Ctxb were loaded on a TGX Stain-free Precast
Protein Gel. Migrated Cetuximab was detected with UV
light by using the Fusion FX Imager (Vilber Lourmat,
Eberhardzell, Germany).
Cell culture
A431 cells and MDA-MB-453 cells were grown in
DMEM High Glucose medium. HK-2 cells were grown
in DMEM:F12 High Glucose medium. TIME cells were
grown in Vascular Cell Basal Medium supplemented with
the Microvascular Endothelial Cell Growth Kit-VEGF.
Finally, THLE-2 cells were cultured by using the BEGM
Bullet kit without gentamycin/amphotericin and epinephr-
ine, but supplemented with 5 ng/mL EGF. All the cultured
cells were supplemented with 10% FBS and 100 u/mL
penicillin-streptomycin and were maintained in a humidi-
ﬁed 37 °C incubator with 5% CO2.
MTS viability assay
The cell viability after exposure to AuNPs-PAA(±Ctxb)
was tested with the CellTiter 96 AQueous One Solution
Cell Proliferation Assay. Cells were seeded into a 96-well
plate (25,000 cells/cm2 for HK-2 and TIME cells;
28,125 cells/cm2 for A431 cells; 31,250 cells/cm2 for
THLE-2 cells; and 43,750 cells/cm2 for MDA-MB-453
Dovepress Daems et al
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cells). After 24 h, the medium was replaced by fresh
medium containing increasing concentrations of nanopar-
ticles (1.56–50.00 µg Au/mL) for incubation periods of 3 h
or 24 h. After the exposure period, the medium was dis-
carded and cells were washed twice with DMEM +10%
FBS to avoid the interference of the AuNPs at 490 nm.
The MTS reagent, prepared according to the manufac-
turer’s instructions, was added to the cells. The plate was
incubated at 37 °C for 1.5 h and the absorbance was
measured at 490 nm with the CLARIOstar microplate
reader (BMS Labtech, De Meern, Netherlands). The cell
viability was calculated as the ratio of the absorbance of
the sample well to the average of the unexposed control
wells, after subtraction of the background signal of wells
that contained AuNPs-PAA(±Ctxb) but no cells. The
results, expressed as percentages, were obtained from at
least three independent experiments with a minimum of
three replicates per condition. Curve ﬁtting of the concen-
tration-response data was performed with Origin 2017
software, by using a log-logistic function and a modiﬁed
log-logistic function (Equation S1 and Equation S2,
respectively).
Live cell imaging
The effect of AuNPs-PAA(±Ctxb) on cell apoptosis was
investigated by recording time-lapse images of the cells
every 2 h during 3 days with the IncuCyte ZOOM system
(Essen BioScience, Hertfordshire, UK). Approximately
15,000–45,000 cells/cm2 were seeded into 96-well plates.
After 24 h, the medium was replaced by fresh medium
containing increasing concentrations of nanoparticles
(1.56–50.00 µg Au/mL). To assess the presence of oxida-
tive stress, cells were also co-incubated with 2 nM NAC.
The IncuCyte Caspase 3/7 Green Reagent and the
IncuCyte Annexin V Red Reagent were added to the cell
media to monitor apoptosis according to the manufac-
turer’s instructions. Built-in software was used to analyze
the images in order to generate the annexin V and caspase
3/7 area data (µm2/well), which was normalized to cell
conﬂuency data (%). The results were obtained from at
least three replicates per condition.
Western blot analysis
To determine EGFR expression, cells were cultured in T25
ﬂasks until 80% conﬂuency. Brieﬂy, cells were rinsed with
ice cold PBS and lysed with lysis buffer (20 mM Tris,
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% sodium
deoxycholate, 1% Nonidet P40, 10% glycerol, pH 7.5)
containing a protease and phosphatase inhibitor tablet.
The protein concentrations were quantiﬁed with the BCA
kit according to the manufacturer’s instructions. 15 µg of
proteins were separated on a 4TGX Stain-free Precast
Protein Gel. After protein transfer onto a nitrocellulose
membrane, the membranes were blocked with 5% non-
fat dry milk in PBS-0.1% Tween (PBS-T) for 2 h at room
temperature. Next, membranes were incubated with rabbit
anti-EGFR antibody diluted 1:1,000 in 5% BSA, or with
mouse anti-β-actin antibody diluted 1:5,000 in 5% non-fat
dry milk, overnight at 4 °C. After washing in PBS-T, the
membranes were incubated with HRP-labeled goat anti-
rabbit antibody diluted 1:10,000 in 5% BSA or HRP-
labeled goat anti-mouse antibody diluted 1:50,000 in 5%
non-fat dry milk for 1 h at room temperature. Protein
detection was performed with the Clarity Western ECL
substrate kit and the Fusion FX Imager (Vilber Lourmat,
Eberhardzell, Germany). Protein bands were quantiﬁed
with Bio1D analysis software (Vilber Lourmat,
Eberhardzell, Germany). The EGFR protein level was
normalized to the level of the housekeeping protein, β-
actin. The results are expressed as mean EGFR expression
relative to the EGFR expression in A431 cells and were
obtained from at least 4 independent replicates.
Transmission electron microscopy and
energy dispersive x-ray spectroscopy
Transmission electron microscopy (TEM) was used to
determine the subcellular localization of the AuNPs-
PAA-Ctxb. Approximately 25,000–45,000 cells/cm2 were
seeded in T175 ﬂasks. After 24 h, the medium was
replaced by fresh medium containing 5.0 µg Au/mL of
AuNPs-PAA-Ctxb for incubation periods of 3 h or 24 h.
After the exposure period, the cells were washed twice
with DMEM +10% FBS, once with PBS, and collected by
trypsinization. Cells were ﬁxed with 2.5% (w/v) glutaral-
dehyde in 0.1 M cacodylate buffer (pH 7.4) at 4 °C during
2.5 h. Next, the cells were washed with 0.2 M cacodylate
buffer and subsequently post-ﬁxed in 1% (v/w) osmic acid
in 0.1 M cacodylate buffer. Finally, samples were dehy-
drated by successive passages in increasing concentrations
of ethanol (30%, 50%, 70%, 85% and 100%), and were
embedded in resin. Ultra-thin sections for TEM analysis
were prepared with an 8,800 ultratome III (LKB,
Sollentuna, Sweden), after which the cells were visualized
with a FEI Tecnai 10 TEM (Thermo Fisher Scientiﬁc,
Zaventem, Belgium) and iTEM software (Olympus, Soft
Daems et al Dovepress
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Imaging Solutions, Muenster, Germany). Energy disper-
sive X-ray spectroscopy (EDS) was performed on repre-
sentative cells with the scanning electron microscope
JEOL 7500F and Jeol JED2300 software (Jeol Benelux,
Zaventem, Belgium).
Inductively coupled plasma mass
spectrometry
Inductively coupled plasma mass spectrometry (ICP-MS)
was used to quantify the cellular gold content after interac-
tion of AuNPs-PAA(±Ctxb) with the cells. Approximately
20,000–40,000 cells/cm2 were seeded in T25 ﬂasks. After
24 h, the medium was replaced by fresh medium containing
5.0 µg Au/mL of AuNPs-PAA(±Ctxb) for incubation peri-
ods of 3 h, 6 h, 12 h or 24 h. After exposure, the cells were
rinsed twice with DMEM +10% FBS, once with PBS, and
collected by trypsinization. Detached cells were washed
twice with DMEM+10% FBS by successive centrifugation.
The cells were counted and re-suspended in 1 ml of Class 1
water. Next, samples were digested with 0.5 ml aqua regia
for 2 h at 110 °C in PFA Savillex® digestion vessels (VWR,
Leuven, Belgium). The samples were evaporated to incipi-
ent dryness, redissolved in 5% HNO3 and then exposed to
UV light in a 705 UV-digester (Metrohm, Zwijndrecht,
Belgium) for 2 h. Beforehand, 100 µL of 30% H2O2 was
added as initiator for the UV digestion. Finally, 0.05% HF
was added to reduce Au memory effects. The Au content in
the samples was determined with an XSeriesII quadrupole
ICP-MS instrument (ThermoFisher Scientiﬁc, Bremen,
Germany). Data was acquired from 20 ms dwell time per
isotope, 200 sweeps per reading, and 5 readings per sample,
resulting in 20 s of measurement time per isotope. A rinsing
time of 150 s was included between each sample. The
elements Re, Ir, Tl were used as internal standards. An
external calibration curve based on 0.5–1–2–5 ng/mL of
Au standards permitted quantiﬁcation of the gold content in
the samples. The results are expressed as mean pg Au/cell
calculated from three replicates per condition obtained from
one experiment.
TMRM assay
The effect of AuNPs-PAA(±Ctxb) on the mitochondrial
membrane potential was assessed by measuring the mito-
chondrial retention of the TMRM dye. Approximately
25,000 cells/cm2 were seeded in 24-well plates. After
24 h, the medium was replaced by fresh medium contain-
ing a non-lethal concentration of nanoparticles (ie 3.0 µg
Au/mL for TIME cells, and 5.0 µg Au/mL for THLE-2
and HK-2 cells) for incubation periods of 30 min, 3 h, 6 h,
12 h or 24 h. The non-lethal concentration was estimated
on the basis of IncuCyte apoptosis data acquired from cells
exposed to AuNPs-PAA. To assess the presence of oxida-
tive stress after 12 h of exposure, cells were also co-
incubated with 2 nM NAC. After the exposure period,
the cells were washed twice with DMEM +10% FBS,
once with PBS, and collected by trypsinization.
Subsequently, cells were re-suspended in full medium
containing 100 nM TMRM dye, and incubated for
20 min at 37 °C. After centrifugation, cells were re-sus-
pended in PBS, and the TMRM intensity was measured in
the FL2-channel of the BD Accuri C6 ﬂow cytometer (BD
Biosciences, Erembodegem, Belgium). The relative aver-
age TMRM intensity was calculated as the ratio of the
TMRM intensity of the sample wells to the average
TMRM intensity of the unexposed control wells, after
subtraction of the background signal from unlabeled
cells. The results were obtained from at least three inde-
pendent experiments with a minimum of three replicates
per condition.
Thioredoxin reductase and glutathione
reductase activity measurements
Approximately 25,000–45,000 cells/cm2 cells were
seeded in 175 cm2 ﬂasks. After 24 h, the medium was
replaced by fresh medium containing a non-lethal con-
centration of nanoparticles (ie 3.0 µg Au/mL for TIME
cells and 5.0 µg Au/mL for THLE-2 and HK-2 cells) for
an incubation period of 12 h. The non-lethal concentra-
tion was estimated on the basis of IncuCyte apoptosis
data acquired from cells exposed to AuNPs-PAA. After
the exposure period, cells were washed twice with
DMEM +10% FBS, once with PBS, and collected by
tryspinization. Subsequently, the cell pellets were re-sus-
pended in ice cold PBS. Next, the cells were centrifuged
and lysed by CelLytic M (100 µl per 107 cells), supple-
mented with a protease inhibitor tablet. After centrifuga-
tion of the samples (14 000 g, 10 min, 4 °C), protein
concentrations were quantiﬁed with the BCA protein
assay kit. Next, the thioredoxin reductase activity and
the glutathione reductase activity in 100 µg of protein
were measured according to the manufacturer’s instruc-
tions. Results are expressed as the average change in
absorbance per minute and are obtained from at least
three independent experiments with a minimum of two
replicates per condition.
Dovepress Daems et al
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Statistical analysis
Results are reported as mean ± standard error (SE). One-
way ANOVA was performed to compare cell groups
exposed to different concentrations of AuNPs-PAA
(±Ctxb), or exposed for different periods of time, with
the unexposed control group, followed by a Dunnett
post-hoc test. Two-way ANOVA was used to analyze the
IncuCyte data in order to compare cell groups exposed to
different concentrations of AuNPs-PAA(±Ctxb) with the
unexposed control group as a function of time, followed
by a Dunnett post-hoc test. A Student’s t-test was used to
compare the means of two groups. For the ICP-MS data, a
Kruskal-Wallis test and a Dunn’s post-hoc test were per-
formed to compare cell groups exposed for different per-
iods of time. A Mann-Whitney test was used to compare
the means of two groups. The statistical analyses were
performed by using Prism 7.02 software. The level of
statistical signiﬁcance is depicted by the number of aster-
isks as follows: *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001.
Results
Size distribution and zeta potential of
AuNPs-PAA(±Ctxb)
First, UV-Vis spectra showed surface plasmon resonance
peaks between 522 and 526 nm, which is characteristic for
nano-sized AuNPs (Figure S1A). The composition of the
AuNPs-PAA-Ctxb and the preserved functionality of
Cetuximab after conjugation were described previously.16,44
Successful conjugation of Cetuximab was also demonstrated
by gel electrophoresis showing that Cetuximab was unable to
migrate when conjugated to AuNPs-PAA, unlike uncoupled
Cetuximab incubated with AuNPs-PAA (Figure S1B). Next,
the AuNPs-PAA(±Ctxb) were characterized in terms of their
size distribution and nanoparticle surface charge. Both these
parameters were determined for the AuNPs-PAA(±Ctxb)
dispersed in Class 1 water, DMEM and DMEM supplemen-
ted with 10% FBS (Table 1). Size measurements demon-
strated peak particle diameters of 4–5 nm for AuNPs-PAA
when dispersed in Class 1 water, DMEM and DMEM with
10% FBS. Conjugation of AuNPs-PAA to Cetuximab
increased the peak particle diameter to 26 nm, 25 nm and
19 nm when dispersed in Class 1 water, DMEM and DMEM
with 10% FBS, respectively. The 5th and 95th percentiles
indicate nanoparticle suspensions that are mainly monodis-
persed. The size distribution curves are presented in
Figure S1C.
The zeta potential values of the AuNPs-PAA and the
AuNPs-PAA-Ctxb dispersed in Class 1 water were
−30.53 mV and −29.27 mV, respectively. The zeta poten-
tial values shifted signiﬁcantly towards less negative
values when AuNPs-PAA and AuNPs-PAA-Ctxb were
dispersed in DMEM (−8.03 mV and −7.59 mV, respec-
tively) or in DMEM with 10% FBS (−8.37 mV and
−7.04 mV, respectively).
The AuNPs-PAA(±Ctxb) used in the following experi-
ments involving cell culture were dispersed in full medium
containing 10% FBS. Table 2 presents a summary of the
experiments, the exposure conditions and a short descrip-
tion of the results.
Cellular internalization of AuNPs-PAA-
Ctxb
Cetuximab targets EGFR and thus can inﬂuence the interac-
tion of AuNPs-PAA-Ctxb with the cells depending on their
EGFR expression. Therefore, we veriﬁed the overexpression
of EGFR in A431 cells by means of Western blot. Compared
to A431 cells, HK-2 cells, THLE-2 cells and TIME cells
displayed an EGFR expression of 26%, 3% and 2%, respec-
tively. MDA-MB-453 cells had the lowest EGFR expression
(0.14%) of all (Figure 1). TEM demonstrated the internaliza-
tion of AuNPs-PAA-Ctxb in all cell types when exposed to
5.0 µg Au/mL of AuNPs-PAA-Ctxb for 3 h or 24 h (Figure 2).
After an exposure period of 3 h, the nanoparticles were present
in small intracellular membrane-bound vesicles, which were
localized mostly in the peri-nuclear region of A431 cells
(Figure 2A), HK-2 cells (Figure 2E) and THLE-2 cells
(Figure 2G). In the EGFR-negative MDA-MB-453 cells,
only a minimal uptake of nanoparticles was observed (Figure
2C). When the exposure period was increased to 24 h, the
number of nanoparticle-containing vesicles and the amount of
AuNPs-PAA-Ctxb in the vesicles appeared to increase in all
cell types. The nanoparticle uptake by the TIME cells was
characterized mainly by large clusters of AuNPs-PAA-Ctxb,
which could be observed at both 3 h (Figure 2I) and 24 h of
exposure (Figure 2J). EDS analysis on representative cells
conﬁrmed the presence of intracellular gold (Figure S2).
We also quantiﬁed the gold content of the cells by means
of ICP-MS after incubation with 5.0 µg Au/mL of AuNPs-
PAA(±Ctxb) for 3 h, 6 h, 12 h and 24 h (Figure 3). It is
important to note that the ICP-MS data represents the inter-
action of AuNPs with the cell surface as well as the uptake
of AuNPs by the cells. The results demonstrated maximum
interaction of AuNPs-PAA-Ctxb with A431 cells after 3 h
Daems et al Dovepress
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(1.09±0.07 pg Au/cell). Then, the AuNPs-PAA-Ctxb con-
tent decreased to a plateau phase after 6 h, which continued
until 24 h of exposure. During the plateau phase, there was
no signiﬁcant difference between AuNPs-PAA and AuNPs-
PAA-Ctxb content (Figure 3A). The MDA-MB-453 cells
showed a small, but signiﬁcant increase in AuNPs-PAA
content after 24 h (0.62±0.11 pg Au/cell) compared to 3 h
of exposure (0.27±0.01 pg Au/cell) (Figure 3B). In HK-2
cells, the AuNPs-PAA(±Ctxb) content increased and
peaked after 6 h of incubation (0.69±0.15 pg Au/cell for
AuNPs-PAA and 0.98±0.07 pg Au/cell for AuNPs-PAA-
Ctxb), after which it decreased gradually (Figure 3C). The
THLE-2 cells demonstrated an increased AuNPs-PAA
(±Ctxb) interaction after 24 h of exposure (0.51±0.02 pg
Au/cell for AuNPs-PAA and 1.59±0.14 pg Au/cell for
AuNPs-PAA-Ctxb) (Figure 3D). Finally, the TIME cells
showed a trend of increasing AuNPs-PAA-Ctxb content
after 12 h (0.38±0.07 pg Au/cell) (Figure 3E). Overall, the
cellular AuNPs-PAA-Ctxb interaction was higher than the
AuNPs-PAA interaction in TIME cells, in THLE-2 cells, in
A431 cells after 3 h, in MDA-MB-453 cells after 3 h, and in
HK-2 cells after 3 h and 6 h (exact p-values of 0.1).
AuNPs-PAA(±Ctxb) reduced the cell
viability
TEM and ICP-MS results clearly showed interactions and
uptake of AuNPs by the cells. Therefore, we assessed the cell
viability after exposure to increasing concentrations of
AuNPs-PAA(±Ctxb) for 3 h and 24 h. MTS assays revealed
that AuNPs-PAA(±Ctxb) reduced cell viability in a concen-
tration- and time-dependent manner (Figure 4). The lowest
observed effect concentration (LOEC) presents the lowest
tested concentration causing a signiﬁcantly reduced cell via-
bility. The LOEC of AuNPs-PAA after 3 h of exposure is
25.0 µgAu/mL for the A431 cells and 12.5 µgAu/mL for the
MDA-MB-453 cells (Figure 4C), the THLE-2 cells (Figure
4G) and the TIME cells (Figure 4I). The HK-2 cells showed
no signiﬁcant reduction in cell viability (Figure 4E) at the
maximum exposure concentration of 50.0 µg/mL. However,
when the exposure period was increased to 24 h, the LOEC
values decreased for all cell types (Table 3). Although expo-
sure to AuNPs-PAA-Ctxb demonstrated a concentration- and
time-dependent cytotoxicity proﬁle comparable to that
described for unconjugated AuNPs, they were signiﬁcantly
less cytotoxic. This difference in cytotoxic effect was gen-
erally observable from exposure to a nanoparticle concentra-
tion of 6.25 µg Au/mL for 24 h for A431 cells (Figure 4B),
MDA-MB-453 cells (Figure 4D), HK-2 cells (Figure 4F) and
THLE-2 cells (Figure 4H). Indeed, the calculated half max-
imal effect concentrations (EC50) of AuNPs-PAA-Ctxb were
signiﬁcantly higher than the EC50 concentrations of AuNPs-
PAA in all cell types, except for the TIME cells (Table 3). In
addition, these EC50 values demonstrated that the cytotoxic
effects of the nanoparticles were also cell type-dependent.
Interestingly, the EGFR-overexpressing A431 cancer cells
were the least sensitive cells. Amongst the healthy cells, the
TIME cells were the most vulnerable for the cytotoxic effects
of the AuNPs-PAA(±Ctxb), whereas the HK-2 cells were the
most resistant.
AuNPs-PAA(±Ctxb) induced apoptosis
The MTS viability assays demonstrated reduced cell viabi-
lity after exposure to AuNPs-PAA(±Ctxb). However, the
assay is based on the metabolic activity of the cells and
gives no further information about the process of cell death.
Therefore, we performed live cell imaging measuring the
caspase 3/7 activity and annexin V labeling, two markers of
apoptosis. The results demonstrated that exposure to
AuNPs-PAA(±Ctxb) caused apoptotic cell death in a con-
centration- and time-dependent manner (Figure 5). In the
ﬁrst 24 h, 50.0 µg Au/mL (red line) and 25.0 µg Au/mL
(purple line) of AuNPs-PAA(±Ctxb) resulted in a signiﬁ-
cant increase in caspase 3/7 activity and annexin V labeling
in all cell types. TIME cells, in addition, showed a signiﬁ-
cant increase in the apoptotic parameters after exposure to
12.5 µg Au/mL of nanoparticles (Figure 5I–T, yellow line).
Table 1 Characterization of the AuNPs-PAA and AuNPs-PAA-
Ctxb dispersed in different media.
Nanoparticle type
Suspension medium AuNPs-PAA AuNPs-PAA-Ctxb
Modus size (nm) [5th and 95th percentile]
Class 1 water 4 [4–14] 26 [13–53]
DMEM 5 [4–11] 25 [13–66]
DMEM +10% FBS 5 [4–11] 19 [12–62]
Zeta potential (mV) + SD
Class 1 water −30.53±0.25 −29.27±0.15
DMEM −8.03±0.27 −7.59±0.45
DMEM +10% FBS −8.37±0.25 −7.04±0.22
Notes: The size was measured with disc centrifugation. The values represent the
modus particle size, the 5th and 95th percentile (nm). The zeta potential values
were assessed with the Nanosizer Nano ZSP and are expressed as the mean
nanoparticle surface charge ± standard deviation (n=3).
Abbreviations: AuNPs, gold nanoparticles; Ctxb, Cetuximab; DMEM, Dulbecco’s
modiﬁed Eagle’s medium; FBS, fetal bovine serum; mV, millivolts; PAA, polyallyla-
mine; SD, standard deviation.
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Extending the exposure period to 48 h, 12.5 µg Au/mL of
AuNPs-PAA (yellow line) signiﬁcantly increased apoptosis
in MDA-MB-453 (Figure 5C–D) cells, HK-2 cells (Figure
5E–F) and THLE-2 cells (Figure 5G–H), whereas 6.25 µg
Au/mL (brown line) also induced signiﬁcant apoptosis in
the TIME cells (Figure 5I–J) and HK-2 cells (Figure 5E–F).
Finally, from 48 h to 72 h, 6.25 µg Au/mL of AuNPs-PAA
(brown line) led to a signiﬁcant number of apoptotic cells in
MDA-MB-453 cells (Figure 5C–D), whereas 3.12 µg Au/
mL of AuNPs-PAA (green line) increased apoptosis signif-
icantly in the TIME cells (Figure 5I–J). Similar to the MTS
assay, the live cell imaging data demonstrated that AuNPs-
PAA-Ctxb are less cytotoxic than the AuNPs-PAA.
Exposure to AuNPs-PAA-Ctxb reduced or delayed the
increase in caspase 3/7 activity and annexin V labeling
compared to exposure to AuNPs-PAA.
AuNPs-PAA(±Ctxb) caused
mitochondrial dysfunction
Live cell imaging identiﬁed apoptosis as the cell death
mechanism after exposure to AuNPs-PAA(±Ctxb). Since
mitochondria are key players in activating apoptosis, we
assessed mitochondrial dysfunction by measuring the
mitochondrial membrane potential after exposure of the
cells to a sub-lethal concentration of AuNPs-PAA(±Ctxb)
(Figure 6). A temporary hyperpolarization of the mito-
chondrial membrane potential was observed in HK-2
cells exposed to AuNPs-PAA-Ctxb (Figure 6A) and in
TIME cells exposed to AuNPs-PAA(±Ctxb) (Figure 6C)
for 3 h. Following 6 h of exposure to AuNPs-PAA(±Ctxb),
the mitochondrial membrane potential of THLE-2 cells
(Figure 6B) was reduced by approximately 11–14%, and
of TIME cells (Figure 6C) by approximately 6–10%,
compared to the unexposed controls. After extending the
exposure period to 12 h, the mitochondrial membrane
potentials of the THLE-2 cells and TIME cells were
further depolarized to 80% and 60%, respectively. Only
exposure to AuNPs-PAA could temporarily reduce the
mitochondrial membrane potential of the HK-2 cells by
15% (Figure 6A). Finally, after 24 h of exposure, the
mitochondrial membrane potential of the THLE-2 cells
and the TIME cells was repolarized to more than 90%
compared to the unexposed control cells. HK-2 cells
exposed to AuNPs-PAA-Ctxb exhibited a signiﬁcant
hyperpolarization. Although AuNPs-PAA-Ctxb led to less
cell death than AuNPs-PAA, no strong differences were
observed in the mitochondrial membrane depolarization of
cells exposed to AuNPs-PAA and those exposed to
AuNPs-PAA-Ctxb.
AuNPs-PAA(±Ctxb) inhibited the activity
of thioredoxin reductase and glutathione
reductase
Thioredoxin reductase (TrxR) and glutathione reductase
(GR) are enzymes involved in the antioxidant defense
mechanism of the cell. TrxR and GR both use NADPH to
reduce thioredoxin (Trx) and glutathione (GSH), respec-
tively, which are in turn used by peroxidases to eliminate
H2O2. Oxidative stress can have a negative effect on mito-
chondrial function. Since an exposure period of 12 h resulted
in the most pronounced mitochondrial membrane depolari-
zation (Figure 6), we measured the TrxR and GR activity in
the cells after exposure to a non-lethal concentration of
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Figure 1 EGFR expression in HK-2 cells, THLE-2 cells, TIME cells and MDA-MB-
453 cells relative to EGFR expression in A431 cells, determined by Western blot.
Results are expressed as mean ± SE and are obtained from at least 4 independent
replicates. Protein bands were normalized against β-actin.
Abbreviations: A431, human epidermoid cancer cells; EGFR, epidermal growth
factor receptor; HK-2, human kidney cells; MDA-MB-453, human breast cancer
cells; SE, standard error; THLE-2, human liver cells; TIME, human telomerase
immortalized microvascular endothelial cells.
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AuNPs-PAA(±Ctxb) for 12 h (Figure 7). Incubation with
AuNPs-PAA(±Ctxb) strongly inhibited the TrxR activity in
HK-2 cells (Figure 7A), THLE-2 cells (Figure 7B) and TIME
cells (Figure 7C) with residual activities of 22.8%, 15.3%
and 6.3%, respectively. In addition, a decrease of the GR
activity was observed, but to a lesser extent than was the case
for TrxR inhibition (with residual activities of 61.2%, 69.2%
and 37.9% for HK-2 cells, THLE-2 cells and TIME cells,
respectively). In general, the inhibitory effects on TrxR and
GR were most profound in TIME cells, followed by THLE-2
cells and HK-2 cells.
The protective effect of N-acetyl L-cysteine
(NAC)
Finally, we investigated the ability of NAC to counteract the
cytotoxicity caused byAuNPs-PAA(±Ctxb). NAC is a potent
thiol-containing anti-oxidant, which can interact with ROS
such as OH− and H2O2 through the reducing capacity of its
thiol-disulﬁde exchange activity. Furthermore, NAC acts as a
precursor of reduced glutathione.45,46 Since an exposure
period of 12 h resulted in the most pronounced mitochondrial
membrane depolarization, the potential protective effect of
NAC was assessed after exposure to a non-lethal concentra-
tion of AuNPs-PAA(±Ctxb) for 12 h. Co-incubation of the
cells with AuNPs-PAA(±Ctxb) and NAC prevented mito-
chondrial membrane depolarization in all cell types after
12 h of exposure (Figure 6). Furthermore, the increases in
caspase 3/7 activity and annexin V labeling were remarkably
reduced (Figure 8) compared to AuNPs-PAA(±Ctxb) expo-
sure without NAC (Figure 5). Indeed, during co-exposure
with NAC, only exposure to the highest AuNPs-PAA(±Ctxb)
concentrations of 50.0 µg Au/mL (red line) and 25.0 µg Au/
mL (purple line) resulted in a signiﬁcant increase in annexin
V and caspase 3/7 labeling in most cell types. In addition, a
concentration of 12.5 µg Au/mL (yellow line) of AuNPs-
PAA resulted in a signiﬁcant increase in annexin V and
caspase 3/7 labeling in MDA-MB-453 cells (Figure 8C–D)
and TIME cells (Figure 8I–J).
Correlation between cell viability, TrxR
activity and mitochondrial membrane
depolarization
The previous results demonstrated that the most sensitive
TIME cells exhibited the strongest mitochondrial membrane
depolarization, the highest basal TrxR activity and the stron-
gest TrxR inhibition. Alternatively, the more resistant HK-2
cells showed a mild mitochondrial membrane depolarization,
the lowest basal TrxR activity and the least TrxR inhibition.
In order to interpret the relation between the cell viability, the
TrxR activity and the mitochondrial membrane potential,
correlation studies were performed. The results highlighted
a clear correlation between: (1) the residual mitochondrial
membrane potential and the cell viability (Figure 9A,
Figure 2 Transmission electron microscopy images demonstrating the internaliza-
tion of AuNPs-PAA-Ctxb in A431 cells (A and B), MDA-MB-453 cells (C and D),
HK-2 cells (E and F), THLE-2 cells (G and H) and TIME cells (I and J). The cells
were exposed to 5.0 µg Au/mL of AuNPs-PAA-Ctxb for 3 h (left column) or 24 h
(right column). Arrows indicate AuNPs-PAA-Ctxb. Images were acquired at differ-
ent magniﬁcations. Size bar =1 µm, N = Nucleus.
Abbreviations: AuNPs-PAA-Ctxb, polyallylamine-coated gold nanoparticles con-
jugated to Cetuximab; A431, human epidermoid cancer cells; HK-2, human kidney
cells; MDA-MB-453, human breast cancer cells, THLE-2, human liver cells; TIME,
human telomerase immortalized microvascular endothelial cells.
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Pearson’s r =0.995), (2) basal TrxR activity and the cell
viability (Figure 9B, Pearson’s r =−0.929), (3) the extent of
TrxR inhibition and the cell viability (Figure 9C, Pearson’s
r =−0.920), and (4) the extent of TrxR inhibition and the
residual mitochondrial membrane potential (Figure 9D,
Pearson’s r =−0.997 for AuNPs-PAA and r =−0.969 for
AuNPs-PAA-Ctxb).
Discussion
Only a limited number of reports have been published
investigating the toxicity of AuNPs on non-cancerous
human cells that were expected to be signiﬁcantly
exposed to AuNPs after in vivo administration. In this
study, we presented a comprehensive evaluation of the
cytotoxicity of polyallylamine-coated AuNPs conjugated
to Cetuximab (AuNPs-PAA-Ctxb) in normal human kid-
ney, liver and microvascular endothelial cells, and com-
pared the toxicity proﬁle with their unconjugated
counterparts (AuNPs-PAA).
TEM images demonstrated that the AuNPs-PAA-Ctxb
were present in intracellular vesicles and thus suggested
that AuNPs-PAA-Ctxb uptake was mediated by endocyto-
sis. The extent of nanoparticle internalization depends on
the AuNPs surface modiﬁcations as well as on the cell
type and the incubation time. Indeed, quantitative ICP-MS
data showed that conjugation of the AuNPs-PAA with
Cetuximab resulted in an overall increased cellular inter-
action. This was observed in the THLE-2 cells and TIME
cells, but less so in the EGFR-negative MDA-MB-453
cells, which potentially use non-speciﬁc uptake routes.
Furthermore, A431 cells and HK-2 cells, with high expres-
sion levels of EGFR, exhibited this higher AuNPs-PAA-
Ctxb interaction, especially after short incubation times of
3 h and 6 h. This observation could be attributed to
Cetuximab, since it promotes a fast receptor-mediated
internalization of AuNPs in A431 cells and in pancreatic
cancer cells after 30 min–2 h.10,47 Furthermore, it has been
demonstrated that intermediate-sized nanoparticles
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Figure 3 Interaction of AuNPs-PAA(±Ctxb) with A431 cells (A), MDA-MB-453 cells (B), HK-2 cells (C), THLE-2 cells (D) and TIME cells (E) quantiﬁed with ICP-MS. The
cells were exposed to 5.0 µg Au/mL of AuNPs-PAA(±Ctxb) for 3 h, 6 h, 12 h or 24 h. Results are expressed as mean pg gold per cell ± SD calculated from 3 replicates per
condition obtained from one experiment. A signiﬁcant difference compared to 3 h of exposure was calculated by a Kruskal-Wallis test and a Dunn’s post-hoc test (*p<0.05).
Abbreviations: A431, human epidermoid cancer cells; Ctxb, Cetuximab; Au, gold; AuNPs-PAA, polyallylamine-coated gold nanoparticles; HK-2, human kidney cells; ICP-
MS, inductively coupled plasma mass spectrometry; MDA-MB-453, human breast cancer cells; SD, standard deviation; THLE-2, human liver cells; TIME, human telomerase
immortalized microvascular endothelial cells.
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(20–60 nm) are endocytosed more efﬁciently than smaller
nanoparticles.48,49 Thus, in addition to receptor targeting,
the overall increased size of the AuNPs-PAA-Ctxb com-
pared to AuNPs-PAA could have facilitated their cellular
uptake. However, we noticed a subsequent decrease in the
gold content in the A431 and HK-2 cells. This could
potentially be related to a reduced cell surface number of
EGFR and/or exocytosis of the AuNPs. In fact,
Figure 4 Cell viability after exposure to AuNPs-PAA (black curves) and AuNPs-PAA-Ctxb (gray curves) of A431 cells (A and B), MDA-MB-453 cells (C and D), HK-2 cells
(E and F), THLE-2 cells (G and H) and TIME cells (I and J). Cells were exposed to increasing concentrations of AuNPs-PAA or AuNPs-PAA-Ctxb for 3 h or 24 h. The
number of viable cells was assessed by MTS assay. The results are expressed as the mean percentage of viable cells relative to the unexposed cells ± SE and are obtained from
at least three independent experiments with a minimum of three replicates per condition. A signiﬁcantly reduced viability compared to the unexposed control was calculated
by a one-way ANOVA and a Dunnett post-hoc test (*p<0.05, **p<0.01, ***p<0.001 ****p<0.0001).
Abbreviations: A431, human epidermoid cancer cells; ANOVA, analysis of variance; AuNPs-PAA, polyallylamine-coated gold nanoparticles; Ctxb, Cetuximab; HK-2, human
kidney cells; MDA-MB-453, human breast cancer cells; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium); SE, standard error;
THLE-2, human liver cells; TIME, human telomerase immortalized microvascular endothelial cells.
Table 3 EC50 values after 24 h of cell exposure and LOEC after 3 h and 24 h of exposure to AuNPs-PAA and AuNPs-PAA-Ctxb.
Cell type AuNPs-PAA AuNPs-PAA-Ctxb
LOEC (3 h) LOEC (24 h) EC50+95% CI (24 h) LOEC (3 h) LOEC (24 h) EC50+95% CI (24 h)
A431 25.0 12.5 13.7 [12.8–14.6] 50.0 25.0 26.9 [24.8–29.1]
MDA-MB-453 12.5 6.25 8.31 [7.67–8.96] 50.0 6.25 12.3 [11.6–13.0]
HK-2 >50 6.25 9.65 [8.60–10.7] >50 12.5 16.7 [15.3–18.2]
THLE-2 12.5 3.12 5.08 [4.36–5.79] 3.12 6.25 9.75 [9.04–10.5]
TIME 12.5 6.25 5.47 [5.18–5.75] 12.5 6.25 5.67 [5.08–6.26]
Note: Values were calculated from the MTS viability assays and expressed as µg Au/mL (Figure 4).
Abbreviations:A431, human epidermoid cancer cells; AuNPs, gold nanoparticles; CI, conﬁdence interval; EC50, Half maximal effect concentration; HK-2, human kidney cells; LOEC,
Lowest observed effect concentration; MDA-MB-453, human breast cancer cells, THLE-2, human liver cells; TIME, human telomerase immortalized microvascular endothelial cells;
Ctxb, cetuximab.
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Figure 5 Live cell imaging for caspase 3/7 activation (left lanes) and annexin V labeling (right lanes) in A431 cells (A and B, K and L), MDA-MB-453 cells (C and D, M and
N), HK-2 cells (E and F, O and P), THLE-2 cells (G and H, Q and R) and TIME cells (I and J, S and T). The cell lines were exposed to increasing concentrations of AuNPs-
PAA or AuNPs-PAA-Ctxb. Time-lapse pictures were taken every 2 h for 72 h. The results are expressed as the mean area of caspase 3/7 or annexin V per well ± SE and are
obtained from at least three replicates. A signiﬁcant increase in caspase 3/7 activity and annexin V labeling compared to unexposed control cells was calculated by a two-way
ANOVA and a Dunnett post-hoc test. The start of signiﬁcance is visualized by vertical bars (*p<0.05, **p<0.01, ***p<0.001 ****p<0.0001).
Abbreviations: A431, human epidermoid cancer cells; ANOVA, analysis of variance; AuNPs-PAA, polyallylamine-coated gold nanoparticles; Ctxb, Cetuximab; HK-2, human
kidney cells; MDA-MB-453, human breast cancer cells; SE, standard error; THLE-2, human liver cells; TIME, human telomerase immortalized microvascular endothelial cells.
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Cetuximab-conjugated AuNPs inhibit the recycling of
EGFR from endosomes to the cell surface more efﬁciently
than free Cetuximab.10,47 This would lead to a prolonged
reduction in the number of docking sites for Cetuximab
and therefore less uptake of the AuNPs-PAA-Ctxb over
time. Furthermore, it has been reported that macropino-
somes in A431 cells diffuse with difﬁculty to lysosomes
and travel back to the extracellular ﬂuid.50,51 No exocyto-
sis processes were reported yet for HK-2 cells. In contrast
to the aforementioned interaction kinetics, the MDA-MB-
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Figure 6 Mitochondrial membrane potential measurements of the HK-2 cells (A), THLE-2 cells (B) and TIME cells (C) after exposure to AuNPs-PAA or AuNPs-PAA-Ctxb.
TIME cells were exposed to 3.0 µg Au/mL, THLE-2 and HK-2 cells were exposed to 5.0 µg Au/mL of AuNPs-PAA or AuNPs-PAA-Ctxb. During the 12 h exposure, 2 nM
NAC was added to assess oxidative stress. The mitochondrial membrane potential was measured with TMRM ﬂuorescence, detected by ﬂow cytometry. The results are
expressed as mean TMRM ﬂuorescent signal relative to the unexposed control cells (red line) ± SE and are obtained from at least three independent experiments with a
minimum of three replicates per condition. Signiﬁcant difference in TMRM signal compared to the unexposed control was calculated by a one-way ANOVA and a Dunnett
post-hoc test (bullets). Signiﬁcant difference in TMRM ﬂuorescent signal between AuNPs-PAA and AuNPs-PAA-Ctxb exposed cells, or between nanoparticle-exposed cells
and NAC co-exposed cells, was calculated by a Student’s t-test (asterisks) (*p<0.05, **p<0.01, ***p<0.001 ****p<0.0001).
Abbreviations: ANOVA, analysis of variance; AuNPs-PAA, polyallylamine-coated gold nanoparticles; Ctxb, Cetuximab; HK-2, human kidney cells; NAC, N-acetyl L-cysteine;
SE, standard error; THLE-2, human liver cells; TIME, human telomerase immortalized microvascular endothelial cells; TMRM, tetramethylrhodamine methyl ester.
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Figure 7 Thioredoxin reductase and glutathione reductase activity in the HK-2 cells (A), THLE-2 cells (B) and TIME cells (C) after exposure to AuNPs-PAA or AuNPs-
PAA-Ctxb. TIME cells were exposed to 3.0 µg Au/mL, THLE-2 and HK-2 cells were exposed to 5.0 µg Au/mL of AuNPs-PAA or AuNPs-PAA-Ctxb for 12 h. The enzyme
activity rate per minute was measured by the increase in absorbance at 405 nm for GR and at 412 nm for TrxR. The results are expressed as mean enzyme activity rate per
minute per 100 µg of protein ± SE and are obtained from at least three independent experiments with a minimum of two replicates per condition. Signiﬁcant difference in
enzyme activity rate compared to the unexposed control was calculated by a Student’s t-test (*p<0.05, **p<0.01, ***p<0.001 ****p<0.0001).
Abbreviations: AuNPs-PAA, polyallylamine-coated gold nanoparticles; Ctxb, Cetuximab; GR, Glutathione reductase; HK-2, human kidney cells; SE, standard error; THLE-2,
human liver cells; TIME, human telomerase immortalized microvascular endothelial cells; TrxR, Thioredoxin reductase.
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Figure 8 Live cell imaging for caspase 3/7 activation (left panels) and annexin V labeling (right panels) in A431 cells (A and B, K and L), MDA-MB-453 cells (C and D, M and
N), HK-2 cells (E and F, O and P), THLE-2 cells (G and H, Q and R) and TIME cells (I and J, S and T). The cell lines were co-exposed to increasing concentrations of
AuNPs-PAA or AuNPs-PAA-Ctxb and 2 nM of NAC. Time-lapse pictures were taken every 2 h for 72 h. The results are expressed as the mean area of caspase 3/7 or
annexin V per well ± SE and are obtained from at least three replicates. A signiﬁcant increase in caspase 3/7 activity and annexin V labeling compared to unexposed control
cells was calculated by a two-way ANOVA and a Dunnett post-hoc test. The start of signiﬁcance is visualized by vertical bars (*p<0.05, **p<0.01, ***p<0.001 ****p<0.0001).
Abbreviations: A431, human epidermoid cancer cells; ANOVA, analysis of variance; AuNPs-PAA, polyallylamine-coated gold nanoparticles; Ctxb, Cetuximab; HK-2, human
kidney cells; MDA-MB-453, human breast cancer cells; SE, standard error; NAC, N-acetyl L-cysteine; THLE-2, human liver cells; TIME, human telomerase immortalized
microvascular endothelial cells.
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453 cells, the TIME cells and the THLE-2 cells showed a
more gradual and progressive increase in AuNPs-PAA
(±Ctxb) content with increasing incubation periods,
which could indicate a less efﬁcient and speciﬁc AuNPs
uptake. Interestingly, despite the relatively low interactions
of AuNPs-PAA(±Ctxb) with the TIME cells, as shown by
ICP-MS (maximum 0.38±0.07 pg Au/cell), the TEM
images demonstrated large intracellular nanoparticle clus-
tering. Nanoparticle clustering was also observed in
human umbilical vein endothelial cells (HUVECs) incu-
bated with 1012 citrate-capped AuNPs/mL for 24 h under
static conditions.52 A possible hypothesis for this observa-
tion is that nanoparticles can be trapped and clustered
within the glycocalyx coating of the endothelial cells.53
Furthermore, the microvascular endothelial cells control
the continuous passage of macromolecules and ﬂuid from
the blood to the extravascular tissue. Therefore, endothe-
lial cells are rich in cell surface invaginations to engulf
proteins, lipids and nanoparticles.54
Since we demonstrated clear, but different interactions
of the AuNPs-PAA(±Ctxb) with the cells, we performed
cell viability assays to investigate the effects of AuNPs-
PAA(±Ctxb) on the different cell types. Our results
showed that the AuNPs-PAA(±Ctxb) toxicity was
increased in a concentration- and time-dependent manner.
In addition, the EC50 values, based on the MTS assays
after 24 h of exposure, demonstrated that various cell types
are differentially sensitive to the effects of the AuNPs.
Interestingly, EGFR-overexpressing A431 cells exhibited
the highest resistance to AuNPs-PAA-Ctxb-induced
Figure 9 Correlation analyses showing the relation between the residual mitochondrial membrane potential and cell viability (A); the basal TrxR activity and cell viability (B);
the extent of TrxR activity and cell viability (C); and the extent of TrxR inhibition and the residual mitochondrial potential (D). Data are presented as mean ± SD (for
mitochondrial membrane potential and TrxR activity) or 95% CI (for EC50). 1= HK-2 cells, 2= THLE-2 cells and 3= TIME cells.
Abbreviations: CI, conﬁdence interval; HK-2, human kidney cells; SD, standard deviation; THLE-2, human liver cells; TIME, human telomerase immortalized microvascular
endothelial cells; TrxR, thioredoxin reductase; AuNPs-PAA, polyallylamine-coated gold nanoparticles; Ctxb, cetuximab; EC50, half maximal effect concentration.
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toxicity (EC50=26.9 µg Au/mL), followed by HK-2 cells
(EC50=16.7 µg Au/mL), MDA-MB-453 cells
(EC50=12.3 µg Au/mL), THLE-2 cells (EC50=9.75 µg
Au/mL) and TIME cells (EC50=5.67 µg Au/mL). These
ﬁndings are not consistent with several other toxicity stu-
dies demonstrating that cancer cells are more sensitive to
nanoparticle-induced toxicity than normal cells and that
antibody-conjugated AuNPs enhance cell death in antigen-
overexpressing cancer cells.13,55–59 In fact, we showed that
conjugation of AuNPs-PAA to Cetuximab even reduced
nanoparticle-induced cytotoxicity, leading to EC50 values
that are 1.5–2 times higher than the EC50 values of the
cells incubated with AuNPs-PAA. This observation could
be attributed to the change in surface coating of AuNPs-
PAA after antibody conjugation, which could reduce the
interaction of gold with biological components.36,60
The calculated EC50 values allow comparison of the
sensitivity of the (normal) cells and the toxicity of our unique
AuNPs-PAA(±Ctxb) with other reports in literature. As such,
the EC50 value of A431 cells after 24 h of exposure to
AuNPs-PAA-Ctxb is 2.5 times lower than the EC50 value
calculated for 30 nm citrate-reduced AuNPs on A431 cells.61
As a result, our AuNPs-PAA-Ctxb have a much higher
capacity to induce cell death in the tumor cells, whereas the
reduced cytotoxicity of the AuNPs-PAA-Ctxb compared to
AuNPs-PAA is advantageous for the normal healthy cells.
Focusing on the kidney cells, incubation of normal human
proximal tubular cells (HPTCs) with 40 nm polyethyleni-
mine-coated AuNPs has shown to activate pathways
involved in apoptosis and DNA damage repair. An EC50
value of 72.18 µg/mL was calculated after 24 h of exposure,
which is approximately 4–7 times higher than the EC50 value
of the HK-2 cells in this study.38 In the liver tissue, the RES is
the main cause of rapid sequestration of AuNPs. Uptake of
5 nm polyvinylpyrrolidone-coated AuNPs (98 µg/mL) in
endocytic vesicles was observed in hepatocytes of rat liver
precision-cut slices.62 This uptake did not translate into sig-
niﬁcant cytotoxicity after 24 h of exposure. The latter is
consistent with 3.2 nm dihydrolipoic-coated gold nanoclus-
ters (24.5 µg/mL) causing no toxicity in the normal human
liver L02 cell line after 72 h of exposure.62,63 In contrast,
production of pro-inﬂammatory cytokines has been demon-
strated in primary rat hepatocytes after 4 h of incubation with
20 nm AuNPs (211.2 µg/mL), showing a higher sensitivity
than liver macrophages.64 Furthermore, a time- and concen-
tration-dependent uptake of 40 nm polyethylenimine-coated
AuNPs in normal human hepatocytes resulted in oxidative
stress. However, the calculated EC50 value of 170 µg/mL
after 24 h of exposure is still 30 times higher than the EC50
value for the THLE-2 cells in this study.39 Finally, we
showed that TIME cells exhibit the highest sensitivity to
AuNPs-PAA(±Ctxb), which could be related to their clus-
tered nanoparticle uptake observed by TEM imaging. It is
noteworthy that the experiments were performed under static
conditions, whereas the endothelial cell layer in particular is
subjected to a continuous blood ﬂow and shear stress in vivo.
Fede et al (2015) revealed that the cytotoxicity of PEG-
coated AuNPs in HUVECs was signiﬁcantly lower under
ﬂow-conditions than under static conditions. However, the
toxicity increased with increasing concentrations and incuba-
tion times, which is consistent with our data.52 Altogether,
our results regarding cell viability and the above-mentioned
reports demonstrate that AuNPs-induced cytotoxicity
depends on the cell type as well as on the nanoparticle size,
coating, concentration and incubation time.
Multiple hypotheses have been proposed regarding
how AuNPs interact with cellular components after endo-
cytosis. For example, endosomal escape could lead to
physical interaction between the AuNPs and biological
components.65,66 Others have reported on gold ion release
due to particle degradation caused by the acidic lysosomal
environment.67–69 In order to gain knowledge regarding
the underlying mechanisms of our AuNPs-PAA(±Ctxb)
cytotoxicity, we assessed apoptosis, mitochondrial dys-
function and measured antioxidant enzyme activities. Our
results demonstrated that AuNPs-PAA(±Ctxb) were able
to decrease the TrxR and GR activity in normal cell types.
Generally, the AuNPs-PAA(±Ctxb) inhibited TrxR more
effectively than GR, which may be ascribed to the high
afﬁnity of gold for the selenocysteine residue present in
the active site of TrxR, but lacking in GR.70 TIME cells
showed the highest basal TrxR and GR activity, followed
by THLE-2 cells and HK-2 cells. The abundance of TrxR
in TIME cells could be related to the Trx system modulat-
ing angiogenic activities, such as endothelial migration,
proliferation and vascular network formation.71,72
Consequently, AuNPs-PAA(±Ctxb) were able to exert a
considerable stronger inhibitory effect on the TrxR (and
GR) of TIME cells than on THLE-2 and HK-2 cells (6.3%
of residual TrxR activity in TIME cells versus in 15.3% in
THLE-2 cells and 22.8% in HK-2 cells). Similar cell type-
dependent differences in TrxR inhibition were reported in
5 cancer cell lines with A431 cells, the most resistant cell
type in our experiments, having the lowest basal TrxR
activity.67,68 Inhibition of TrxR and GR creates a lack of
reduced Trx and GSH, which are needed as substrates for
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peroxidases to eliminate H2O2. The disturbance in the thiol
redox balance can lead to oxidative stress causing mito-
chondrial dysfunction.73 Indeed, our results demonstrated
a substantial depolarization of the mitochondrial mem-
brane potential after 12 h of AuNPs incubation, especially
in TIME cells (60.4% of control ﬂuorescence), in THLE-2
cells (79.2% of control ﬂuorescence) and to a lesser extent
in HK-2 cells (84.8% of control ﬂuorescence).
Furthermore, a strong correlation was observed between
the extent of TrxR inhibition and the mitochondrial mem-
brane depolarization (Figure 9D). The correlation analyses
including EC50 values (Figure 9A–C) indicate that the
sensitivity of the cells to AuNPs-PAA(±Ctxb) was strongly
associated with the basal TrxR activity, the extent of TrxR
inhibition and the mitochondrial membrane depolarization.
Alternatively, EGFR expression and cellular AuNPs-PAA
(±Ctxb) interaction were less decisive, as shown by ICP-
MS (maximum gold content of 0.98 pg/cell in HK-2 cells
compared to 0.38 pg/cell in TIME cells).
Notably, the mitochondrial membrane depolarization
recovered almost completely after 24 h of exposure to a
sub-lethal concentration of AuNPs-PAA(±Ctxb). A possible
explanation is given by Penninckx et al, who demonstrated a
substantial increase of autophagic activity in A549 after 12–
18 h of AuNPs incubation, but no longer after 24 h.67 In
addition, exposure to 50 nm citrate-capped AuNPs caused
autophagy in HK-2 cells, promoting their cell survival.74
This suggests that autophagy could be responsible for the
observed cell recovery by providing energy through the
lysosomal degradation of cytoplasmic constituents.
However, next to serving as a cell survival mechanism,
autophagy can also mediate the induction of apoptosis after
exposure to AuNPs.74 Furthermore, a link exists between
apoptosis and the Trx system. More speciﬁcally, reduced
Trx interacts with the apoptosis signaling kinase-1 (ASK-1)
and prevents its homodimerization and activation. As Trx
becomes oxidized, it dissociates from the complex andASK1
induces the mitochondrial-dependent apoptotic pathway.71,72
Since AuNPs-PAA(±Ctxb) caused a strong TrxR inhibition,
it can lead to a lack of reduced Trx and a pro-apoptotic status.
The live cell imaging results showed that exposure to
AuNPs-PAA(±Ctxb) provoked a concentration-and time-
dependent activation of caspase 3/7 and annexin V labeling,
identifying apoptosis as a major mechanism of cell death.
We further veriﬁed the central role of oxidative stress in
AuNPs-induced cytotoxicity by co-incubation of the cells
with AuNPs-PAA(±Ctxb) and NAC. In addition to its anti-
oxidant function, NAC acts as a precursor for reduced
glutathione and can replenish the depleted intracellular glu-
tathione content. The latter has been observed in human
leukemia cells, human hepatoma cells and normal human
ﬁbroblasts following exposure to AuNPs.75,76 The results
showed that co-incubation of the cells with NAC avoided
the mitochondrial membrane depolarization and signiﬁ-
cantly reduced apoptotic cell death. This is consistent with
results demonstrating that pre-exposure of HeLa cells and
MCF-7 cells with NAC, glutathione, and triphenylpho-
sphine monosulfonate (TPPMS) increased cell survival dur-
ing exposure to 1.4 nm TPPMS-coated AuNPs and 3–
10 nm chitosan-coated AuNPs.29,55 However, pre-exposure
with ascorbic acid, a non-thiol containing antioxidant, did
not signiﬁcantly reduce the toxicity of the AuNPs.
Therefore, Pan et al (2009) suggested that thiol-containing
antioxidants not only reduced the oxidative stress caused by
the nanoparticles, but also could neutralize the AuNPs
interactions with vital biological targets.29
Altogether, our ﬁndings in normal cells complement other
studies demonstrating that AuNPs disturb the cellular redox
balance, trigger mitochondrial dysfunction and could lead to
apoptosis in various cancer cells.29,56–58,67–69,77–80 In fact, the
inhibition of TrxR and the mitochondrial dysfunction have
been identiﬁed as important biological aspects of the AuNPs
radiosensitization mechanism in therapeutic radiotherapy.68,78
Consequently, basal TrxR activity could possibly be used as a
tool to estimate the sensitivity of normal cells to AuNPs when
a signiﬁcant accumulated dose of AuNPs is expected after
administration. It should be noted that the results of this study
are based on one speciﬁc cell line originating from either the
kidney, the liver or the microvasculature, and therefore war-
rants further in vivo testing. Furthermore, this study stimulates
future research to investigate AuNPs toxicity in normal human
cells and tissues that encounter a signiﬁcant dose of AuNPs
after in vivo administration.
Conclusion
Since only a limited number of reports have been pub-
lished investigating the toxicity of AuNPs on normal
human cells, the present study complements the literature
on the inhibitory effects of AuNPs investigated in cancer
cells. The results of this study point out a general mechan-
ism of cytotoxicity induced by AuNPs-PAA(±Ctxb).
However, the sensitivity to AuNPs-PAA(±Ctxb) is cell-
type dependent according to the cell type characteristics.
More speciﬁcally, basal TrxR activity, TrxR inhibition and
mitochondrial membrane depolarization were clearly cor-
related with the sensitivity of the cells to AuNPs-PAA
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(±Ctxb). In contrast, EGFR expression and the subsequent
cellular interactions with AuNPs-PAA(±Ctxb) were less
clear cut. Furthermore, we demonstrated that conjugation
to Cetuximab reduced the cytotoxicity of the AuNPs-PAA,
potentially due to the change in surface coating. This study
paves the way to investigate basal TrxR activity as a
potential tool to predict which healthy cells and tissues
could exhibit a high sensitivity to AuNPs after adminis-
tration. This supports the understanding of the risks asso-
ciated with the use of AuNPs in vivo.
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Supplementary materials
y ¼ k
1þ xx50
 s
Equation S1 Log-logistic function for curve ﬁtting of the
MTS viability data.
y ¼ k 1þ gxð Þ
1þ 1þ 2gx50ð Þ xx50
 s
Equation S2 Modiﬁed log-logistic function for curve ﬁt-
ting of the MTS viability data.
In both equations, y represents the experimental cell
viability, x is the gold concentration and S deﬁnes the
slope parameter. Moreover, k is the response at x=0 and
x50 is the gold concentration at which the cell viability is
reduced by 50% compared to control response. Finally, in
the second equation, g represents the hormesis parameter,
modelling a potential stimulatory effect of low gold
concentrations.
Figure S1 UV-Vis spectrum of AuNPs-PAA and AuNPs-PAA-Ctxb (A). Gel electrophoresis of Ctxb, AuNPs-PAA + Ctxb and AuNPs-PAA-Ctxb (B). Size distribution curves
(relative number) of AuNPs-PAA and AuNPs-PAA-Ctxb in Class 1 water, DMEM and DMEM +10% FBS obtained from CPS Disk Centrifugation (Benelux Scientiﬁc, Eke,
Belgium) (C).
Abbreviations: AuNPs-PAA, polyallylamine-coated gold nanoparticles; Ctxb, Cetuximab; FBS, Fetal bovine serum; DMEM, Dulbecco’s Modiﬁed Eagle Medium.
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Figure S2 Energy dispersive X-ray spectroscopy analysis on a representative THLE-2 cell (A), a TIME cell (G) and a HK-2 cell (M, N), which were treated with 5 µg Au/mL
of AuNPs-PAA-Ctxb for 3 h or 24 h. Gold mapping was performed on the THLE-2 cell (B) and the TIME cell (H). Bright signal zones (red squares) were analyzed resulting in
speciﬁc X-ray spectra (C, I, O) and quantiﬁcation of gold, carbon and oxygen (E, K, Q). No-signal zones (blue squares) were analyzed resulting in speciﬁc X-ray spectra (D,
J, P) and the detection of only carbon and oxygen (F, L, R).
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